Publications in collaboration with researchers from Duke University (5)

2023

  1. Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials

    Thrombosis Research, Vol. 230, pp. 27-32

2022

  1. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial

    The Lancet Haematology, Vol. 9, Núm. 8, pp. e594-e604

2015

  1. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014

    Journal of Clinical Oncology, Vol. 33, Núm. 6, pp. 654-656

2005

  1. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients

    Thrombosis and Haemostasis, Vol. 94, Núm. 4, pp. 750-759

2004

  1. Compliance with recommended prophylaxis for venous thromboembolism: Improving the use and rate of uptake of clinical practice guidelines

    Journal of Thrombosis and Haemostasis, Vol. 2, Núm. 2, pp. 221-227